© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
XOMA Royalty Corp. (XOMA) stock surged +1.07%, trading at $41.38 on NASDAQ, up from the previous close of $40.94. The stock opened at $41.00, fluctuating between $40.61 and $41.55 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 30, 2026 | 40.98 | 41.72 | 40.78 | 40.94 | 822.73K |
| Apr 29, 2026 | 40.93 | 41.71 | 40.70 | 40.99 | 711.51K |
| Apr 28, 2026 | 41.60 | 42.10 | 40.74 | 40.86 | 913.88K |
| Apr 27, 2026 | 41.22 | 42.81 | 40.50 | 41.97 | 3.18M |
| Apr 23, 2026 | 39.23 | 39.23 | 37.77 | 37.89 | 61.23K |
| Apr 22, 2026 | 39.87 | 40.15 | 38.40 | 39.37 | 150.53K |
| Apr 21, 2026 | 39.89 | 40.45 | 39.26 | 39.58 | 101.59K |
| Apr 20, 2026 | 39.42 | 40.50 | 39.17 | 40.00 | 110.05K |
| Apr 17, 2026 | 40.47 | 40.74 | 39.36 | 39.71 | 174.15K |
| Apr 16, 2026 | 39.95 | 40.70 | 39.05 | 39.61 | 106.33K |
| Apr 14, 2026 | 38.62 | 40.00 | 38.62 | 39.41 | 138.17K |
| Apr 13, 2026 | 36.71 | 39.45 | 36.71 | 38.65 | 229.87K |
| Apr 10, 2026 | 36.79 | 36.94 | 35.78 | 36.74 | 84.87K |
| Apr 09, 2026 | 34.71 | 37.00 | 34.69 | 36.76 | 305.97K |
| Apr 08, 2026 | 35.00 | 35.00 | 33.28 | 34.66 | 183.39K |
| Apr 07, 2026 | 33.80 | 35.04 | 33.10 | 34.58 | 213.28K |
| Apr 06, 2026 | 33.22 | 33.90 | 33.01 | 33.75 | 119.38K |
| Apr 02, 2026 | 32.33 | 33.42 | 32.11 | 32.98 | 93.54K |
| Apr 01, 2026 | 31.85 | 34.00 | 31.58 | 33.08 | 169.81K |
| Mar 31, 2026 | 30.80 | 31.57 | 30.02 | 31.37 | 123.62K |
XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
| Employees | 13 |
| Beta | 0.83 |
| Sales or Revenue | $4.76M |
| 5Y Sales Change% | -0.345% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |